Skip to main content

Peer Review reports

From: The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach

Original Submission
27 Aug 2021 Submitted Original manuscript
16 Oct 2021 Reviewed Reviewer Report - Michele Fornaro
5 Nov 2021 Reviewed Reviewer Report
22 Nov 2021 Author responded Author comments - Christoph U. Correll
Resubmission - Version 2
22 Nov 2021 Submitted Manuscript version 2
30 Nov 2021 Author responded Author comments - Christoph U. Correll
Resubmission - Version 3
30 Nov 2021 Submitted Manuscript version 3
8 Dec 2021 Author responded Author comments - Christoph U. Correll
Resubmission - Version 4
8 Dec 2021 Submitted Manuscript version 4
Publishing
17 Dec 2021 Editorially accepted
10 Jan 2022 Article published 10.1186/s12888-022-03685-w

You can find further information about peer review here.

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us